Ravi Ubriani

563 citations
6 papers · 370 indexed · h-index 5
Topics
Lymphoma Diagnosis and Treatment (3 papers)Cutaneous lymphoproliferative disorders research (3 papers)Fungal Infections and Studies (2 papers)
Partner nations
United StatesCanada

In The Last Decade

Ravi Ubriani

5 papers receiving 363 citations

Peers

Ravi Ubriani
Comparison fields: 5 of 46
  • Dermatology 310
  • Immunology 173
  • Pathology and Forensic Medicine 162
  • Epidemiology 133
  • Oncology 56
Replace H. S. Zackheim with:
H. S. Zackheim United States
Elisabeth A. Fraser-Andrews United Kingdom
Johanna Eder Austria
Maria Gluud Denmark
Sonja Hahtola Finland
Anjali V. Morales United States
Carrie van der Weyden Australia
G�nter Burg Switzerland
Laszlo J. Karai United States
Silvia Ferreira United Kingdom
Ravi Ubriani relative to H. S. Zackheim United States H. S. Zackheim's profile →
Citations per field
00.5×
H. S. Zackheim · 1×
Citations per year

Countries citing papers authored by Ravi Ubriani

Since Specialization
Citations

This map shows the geographic impact of Ravi Ubriani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Ubriani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Ubriani more than expected).

Fields of papers citing papers by Ravi Ubriani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Ubriani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Ubriani. The network helps show where Ravi Ubriani may publish in the future.

Co-authorship network of co-authors of Ravi Ubriani

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Ubriani. A scholar is included among the top collaborators of Ravi Ubriani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Ubriani. Ravi Ubriani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Ravi Ubriani

Ravi Ubriani is a scholar working on Dermatology, Pathology and Forensic Medicine and Statistics, Probability and Uncertainty, having authored 6 papers that have together received 370 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Cutaneous lymphoproliferative disorders research (3 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Dermatology (310 citations), Pathology and Forensic Medicine (162 citations) and Immunology (173 citations). Ravi Ubriani has collaborated with scholars based in United States and Canada. Frequent co-authors include Alain H. Rook, Ellen J. Kim, Stephen D. Hess, Maria Wysocka, Louise C. Showe, Sara Newton, Jacqueline M. Junkins‐Hopkins, Bernice Benoit, Carmela C. Vittorio and Stephen K. Richardson. Their work appears in journals such as Journal of Clinical Investigation, Journal of the American Academy of Dermatology and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026